| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Janus Kinase 2 | 7 | 2010 | 138 | 1.160 |
Why?
|
| Polycythemia Vera | 5 | 2008 | 41 | 0.880 |
Why?
|
| Translocation, Genetic | 3 | 2017 | 344 | 0.580 |
Why?
|
| Immunophenotyping | 3 | 2018 | 332 | 0.560 |
Why?
|
| Erythroid Precursor Cells | 4 | 2010 | 19 | 0.550 |
Why?
|
| Chloroplasts | 4 | 2000 | 8 | 0.510 |
Why?
|
| DNA-Directed DNA Polymerase | 4 | 2002 | 87 | 0.500 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2010 | 633 | 0.470 |
Why?
|
| Philadelphia Chromosome | 1 | 2014 | 41 | 0.420 |
Why?
|
| Cytogenetic Analysis | 1 | 2014 | 78 | 0.420 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2014 | 43 | 0.420 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2014 | 52 | 0.420 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2014 | 895 | 0.410 |
Why?
|
| Myeloid Cells | 1 | 2014 | 113 | 0.400 |
Why?
|
| Lymphocytes | 1 | 2014 | 344 | 0.380 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 159 | 0.370 |
Why?
|
| Cell Lineage | 1 | 2014 | 349 | 0.370 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2019 | 614 | 0.350 |
Why?
|
| Apoptosis | 9 | 2019 | 1827 | 0.340 |
Why?
|
| Point Mutation | 2 | 2008 | 333 | 0.320 |
Why?
|
| Adipose Tissue, Brown | 4 | 1991 | 89 | 0.310 |
Why?
|
| Plant Proteins | 3 | 2000 | 86 | 0.310 |
Why?
|
| Pyrimidines | 3 | 2008 | 446 | 0.310 |
Why?
|
| Leukemia | 2 | 2020 | 387 | 0.300 |
Why?
|
| Signal Transduction | 5 | 2019 | 4686 | 0.300 |
Why?
|
| Flow Cytometry | 5 | 2018 | 765 | 0.290 |
Why?
|
| Alleles | 4 | 2010 | 1673 | 0.290 |
Why?
|
| Triterpenes | 2 | 2005 | 22 | 0.270 |
Why?
|
| Neoplasms, Second Primary | 2 | 2021 | 142 | 0.270 |
Why?
|
| Saponins | 4 | 2008 | 20 | 0.240 |
Why?
|
| T-Lymphocytes | 4 | 2021 | 1722 | 0.240 |
Why?
|
| Sezary Syndrome | 2 | 2008 | 13 | 0.240 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 1586 | 0.240 |
Why?
|
| Down Syndrome | 1 | 2008 | 233 | 0.230 |
Why?
|
| Cell Proliferation | 5 | 2010 | 2465 | 0.230 |
Why?
|
| Piperazines | 1 | 2007 | 265 | 0.220 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 72 | 0.220 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2022 | 17 | 0.190 |
Why?
|
| Enzyme Activation | 5 | 2008 | 576 | 0.180 |
Why?
|
| Mitochondria | 4 | 1992 | 785 | 0.180 |
Why?
|
| Lymphoma | 1 | 2005 | 327 | 0.180 |
Why?
|
| Telomere Shortening | 1 | 2021 | 33 | 0.170 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2001 | 11 | 0.170 |
Why?
|
| Glycoproteins | 2 | 2000 | 346 | 0.160 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2022 | 156 | 0.160 |
Why?
|
| Base Sequence | 6 | 2007 | 2730 | 0.160 |
Why?
|
| Atovaquone | 1 | 2019 | 11 | 0.150 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 81 | 0.150 |
Why?
|
| Proteins | 1 | 2005 | 1006 | 0.150 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2019 | 15 | 0.150 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2019 | 11 | 0.150 |
Why?
|
| Azacitidine | 1 | 2019 | 52 | 0.150 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 142 | 0.140 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 241 | 0.140 |
Why?
|
| Lymphoma, T-Cell | 1 | 2019 | 60 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 1 | 2000 | 258 | 0.140 |
Why?
|
| Mutation, Missense | 3 | 2007 | 919 | 0.140 |
Why?
|
| Adipose Tissue | 1 | 2001 | 502 | 0.130 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 214 | 0.130 |
Why?
|
| Cancer Survivors | 1 | 2021 | 283 | 0.130 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 195 | 0.130 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 197 | 0.130 |
Why?
|
| Viruses | 1 | 2018 | 117 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2017 | 145 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2017 | 137 | 0.130 |
Why?
|
| Mutation | 5 | 2010 | 6099 | 0.120 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2016 | 11 | 0.120 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2019 | 289 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 1 | 2019 | 638 | 0.120 |
Why?
|
| Humans | 27 | 2022 | 131163 | 0.120 |
Why?
|
| Graft Survival | 1 | 2018 | 465 | 0.120 |
Why?
|
| Bone Marrow | 4 | 2019 | 317 | 0.120 |
Why?
|
| Hot Temperature | 3 | 1990 | 137 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2018 | 285 | 0.110 |
Why?
|
| Age Factors | 2 | 2014 | 2825 | 0.110 |
Why?
|
| Cytochrome c Group | 2 | 1992 | 12 | 0.110 |
Why?
|
| Child, Preschool | 7 | 2019 | 15110 | 0.110 |
Why?
|
| NADPH Dehydrogenase | 2 | 2005 | 6 | 0.110 |
Why?
|
| DNA Primers | 3 | 2007 | 599 | 0.110 |
Why?
|
| DNA, Complementary | 3 | 2000 | 422 | 0.110 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 3748 | 0.110 |
Why?
|
| Intellectual Disability | 1 | 2022 | 1089 | 0.110 |
Why?
|
| Child | 9 | 2021 | 26341 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 953 | 0.100 |
Why?
|
| Graft Rejection | 1 | 2018 | 552 | 0.100 |
Why?
|
| Antigens, Surface | 1 | 2014 | 112 | 0.100 |
Why?
|
| Escherichia coli | 1 | 2000 | 991 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2014 | 825 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2008 | 2885 | 0.100 |
Why?
|
| Cold Temperature | 2 | 1990 | 80 | 0.100 |
Why?
|
| Molecular Sequence Data | 4 | 2002 | 3464 | 0.100 |
Why?
|
| Oxygen Consumption | 2 | 1991 | 294 | 0.100 |
Why?
|
| Erythropoietin | 3 | 2008 | 102 | 0.090 |
Why?
|
| Infant | 6 | 2019 | 13352 | 0.090 |
Why?
|
| Prognosis | 3 | 2019 | 4886 | 0.090 |
Why?
|
| Neuroblastoma | 1 | 2017 | 546 | 0.090 |
Why?
|
| Transduction, Genetic | 2 | 2016 | 276 | 0.090 |
Why?
|
| Female | 14 | 2021 | 70963 | 0.090 |
Why?
|
| Cloning, Molecular | 4 | 2002 | 780 | 0.090 |
Why?
|
| Oxidation-Reduction | 4 | 2005 | 436 | 0.090 |
Why?
|
| Rats, Inbred Strains | 5 | 1992 | 181 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 1071 | 0.090 |
Why?
|
| Male | 16 | 2021 | 64957 | 0.090 |
Why?
|
| Cytochromes | 1 | 1990 | 7 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2016 | 768 | 0.080 |
Why?
|
| Acclimatization | 1 | 1990 | 20 | 0.080 |
Why?
|
| Janus Kinase 3 | 1 | 2010 | 16 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2010 | 1571 | 0.080 |
Why?
|
| Spiro Compounds | 1 | 2010 | 12 | 0.080 |
Why?
|
| Triiodothyronine | 1 | 1990 | 50 | 0.080 |
Why?
|
| Thyroxine | 1 | 1990 | 53 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2007 | 157 | 0.080 |
Why?
|
| Langerhans Cells | 1 | 2010 | 23 | 0.080 |
Why?
|
| Glycosylation | 2 | 2000 | 127 | 0.080 |
Why?
|
| Oxidoreductases | 1 | 1990 | 105 | 0.080 |
Why?
|
| Epidermis | 1 | 2010 | 62 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2008 | 248 | 0.080 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 2 | 2010 | 10 | 0.080 |
Why?
|
| Animals | 16 | 2022 | 33912 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 2 | 2008 | 229 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 2018 | 1147 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2008 | 909 | 0.070 |
Why?
|
| Diploidy | 1 | 2008 | 40 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 3 | 2007 | 1447 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2304 | 0.070 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2008 | 8 | 0.070 |
Why?
|
| Mice | 9 | 2022 | 18301 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2008 | 1013 | 0.070 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2007 | 13 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 2395 | 0.070 |
Why?
|
| Phenotype | 1 | 2017 | 4497 | 0.070 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2008 | 105 | 0.070 |
Why?
|
| Liver | 4 | 2019 | 1796 | 0.070 |
Why?
|
| Adolescent | 5 | 2021 | 20987 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 165 | 0.070 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2005 | 25 | 0.070 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2007 | 22 | 0.070 |
Why?
|
| Rats | 6 | 2004 | 3370 | 0.060 |
Why?
|
| Imatinib Mesylate | 1 | 2007 | 47 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 76 | 0.060 |
Why?
|
| Granulocytes | 1 | 2007 | 69 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2007 | 61 | 0.060 |
Why?
|
| Purines | 1 | 2007 | 118 | 0.060 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2006 | 4 | 0.060 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2010 | 233 | 0.060 |
Why?
|
| Methemoglobinemia | 1 | 2006 | 9 | 0.060 |
Why?
|
| STAT5 Transcription Factor | 1 | 2007 | 93 | 0.060 |
Why?
|
| Pyrroles | 1 | 2008 | 188 | 0.060 |
Why?
|
| Culture Media | 1 | 2007 | 171 | 0.060 |
Why?
|
| Benzamides | 1 | 2007 | 127 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 905 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2007 | 1826 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2005 | 975 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2019 | 3819 | 0.060 |
Why?
|
| Cell Survival | 2 | 2019 | 826 | 0.060 |
Why?
|
| Cytokinesis | 1 | 2005 | 23 | 0.060 |
Why?
|
| Terpenes | 1 | 2005 | 30 | 0.060 |
Why?
|
| Schizosaccharomyces | 1 | 2005 | 62 | 0.060 |
Why?
|
| Exons | 1 | 2007 | 759 | 0.060 |
Why?
|
| NAD | 2 | 2005 | 52 | 0.060 |
Why?
|
| Benzo(a)pyrene | 1 | 2005 | 28 | 0.060 |
Why?
|
| Insulin | 1 | 1990 | 1149 | 0.060 |
Why?
|
| Ubiquitins | 1 | 2005 | 39 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2005 | 128 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 1011 | 0.050 |
Why?
|
| Sex Factors | 1 | 2008 | 1356 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2002 | 254 | 0.050 |
Why?
|
| Autophagy | 1 | 2007 | 417 | 0.050 |
Why?
|
| Young Adult | 2 | 2018 | 10103 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 680 | 0.050 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 573 | 0.050 |
Why?
|
| CD3 Complex | 2 | 2016 | 96 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2008 | 1692 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1801 | 0.050 |
Why?
|
| Quinone Reductases | 1 | 2002 | 3 | 0.050 |
Why?
|
| Vitamin K 3 | 1 | 2002 | 5 | 0.050 |
Why?
|
| Electron Transport | 3 | 1992 | 60 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 1205 | 0.050 |
Why?
|
| Cell Line | 1 | 2007 | 2552 | 0.050 |
Why?
|
| DNA, Plant | 1 | 2002 | 7 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2002 | 11 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2004 | 269 | 0.040 |
Why?
|
| Exodeoxyribonuclease V | 1 | 2002 | 28 | 0.040 |
Why?
|
| Exodeoxyribonucleases | 1 | 2002 | 52 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 623 | 0.040 |
Why?
|
| FMN Reductase | 1 | 2001 | 7 | 0.040 |
Why?
|
| NADP | 1 | 2001 | 57 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2021 | 119 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 201 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2005 | 722 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 1336 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 236 | 0.040 |
Why?
|
| Abdomen | 1 | 2001 | 126 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2019 | 17753 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2022 | 213 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 1363 | 0.040 |
Why?
|
| Guanosine Triphosphate | 1 | 2000 | 38 | 0.040 |
Why?
|
| Genetic Complementation Test | 1 | 2000 | 89 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2000 | 47 | 0.040 |
Why?
|
| Luciferases | 1 | 2000 | 127 | 0.040 |
Why?
|
| Hydrogen Peroxide | 2 | 1990 | 116 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 34 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 1999 | 1939 | 0.040 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2000 | 65 | 0.040 |
Why?
|
| DNA Replication | 1 | 2002 | 355 | 0.040 |
Why?
|
| Arabinose | 1 | 1999 | 23 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 300 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 2323 | 0.040 |
Why?
|
| Protein Sorting Signals | 1 | 1999 | 44 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 5196 | 0.040 |
Why?
|
| Light | 1 | 2000 | 166 | 0.040 |
Why?
|
| Molecular Weight | 1 | 1999 | 276 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2021 | 3359 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2010 | 46 | 0.040 |
Why?
|
| Temperature | 1 | 2000 | 291 | 0.040 |
Why?
|
| Plant Leaves | 1 | 1999 | 51 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2019 | 77 | 0.040 |
Why?
|
| Caspase 3 | 2 | 2010 | 121 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 1999 | 198 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2007 | 2550 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 1999 | 172 | 0.040 |
Why?
|
| Biological Transport | 1 | 1999 | 329 | 0.040 |
Why?
|
| Protein Precursors | 1 | 1999 | 140 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2005 | 4738 | 0.040 |
Why?
|
| Species Specificity | 1 | 1999 | 470 | 0.040 |
Why?
|
| Uganda | 1 | 2018 | 85 | 0.040 |
Why?
|
| Organ Specificity | 1 | 1999 | 394 | 0.040 |
Why?
|
| Remission Induction | 1 | 2019 | 306 | 0.040 |
Why?
|
| Gene Rearrangement | 1 | 2020 | 323 | 0.030 |
Why?
|
| Triglycerides | 1 | 2001 | 602 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 1075 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2022 | 760 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 1999 | 325 | 0.030 |
Why?
|
| Chromosome Banding | 1 | 2017 | 135 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1490 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4697 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 1999 | 448 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2019 | 357 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 569 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 352 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2001 | 1117 | 0.030 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2017 | 125 | 0.030 |
Why?
|
| Transplant Recipients | 1 | 2018 | 235 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 1207 | 0.030 |
Why?
|
| Viral Load | 1 | 2018 | 416 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2016 | 44 | 0.030 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2016 | 48 | 0.030 |
Why?
|
| Kidney | 2 | 2001 | 1282 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 2016 | 58 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2010 | 480 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 653 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 2026 | 0.030 |
Why?
|
| Retroviridae | 1 | 2016 | 182 | 0.030 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 328 | 0.030 |
Why?
|
| Virus Replication | 1 | 2018 | 608 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2016 | 272 | 0.030 |
Why?
|
| Rituximab | 1 | 2016 | 170 | 0.030 |
Why?
|
| Calcium | 1 | 2000 | 1010 | 0.030 |
Why?
|
| Mitochondria, Liver | 2 | 1992 | 37 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 663 | 0.030 |
Why?
|
| Adult | 4 | 2021 | 31282 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1239 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 2406 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2016 | 892 | 0.020 |
Why?
|
| Ubiquinone | 1 | 1992 | 23 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 544 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 1992 | 97 | 0.020 |
Why?
|
| Models, Biological | 3 | 1992 | 1371 | 0.020 |
Why?
|
| Glycerophosphates | 1 | 1991 | 4 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 1991 | 22 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1991 | 40 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 4066 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 1991 | 43 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2010 | 64 | 0.020 |
Why?
|
| Mannose-Binding Lectins | 1 | 2010 | 27 | 0.020 |
Why?
|
| STAT Transcription Factors | 1 | 2010 | 24 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 1339 | 0.020 |
Why?
|
| Basal Metabolism | 1 | 1990 | 93 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 62 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 114 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2010 | 71 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2010 | 111 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 1280 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 1990 | 258 | 0.020 |
Why?
|
| Binding Sites | 1 | 1991 | 1133 | 0.020 |
Why?
|
| Receptors, Erythropoietin | 1 | 2008 | 11 | 0.020 |
Why?
|
| Caspase Inhibitors | 1 | 2008 | 30 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2008 | 40 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2008 | 64 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2010 | 410 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 189 | 0.020 |
Why?
|
| Fusion Regulatory Protein 1, Heavy Chain | 1 | 2007 | 4 | 0.020 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2007 | 13 | 0.020 |
Why?
|
| Chloroquine | 1 | 2007 | 30 | 0.020 |
Why?
|
| Beclin-1 | 1 | 2007 | 33 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6459 | 0.020 |
Why?
|
| Kinetics | 2 | 2004 | 1088 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 366 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 992 | 0.020 |
Why?
|
| DNA Probes | 1 | 2007 | 117 | 0.020 |
Why?
|
| Clone Cells | 1 | 2007 | 153 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2006 | 147 | 0.020 |
Why?
|
| Piperidines | 1 | 2008 | 223 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2008 | 645 | 0.010 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2007 | 170 | 0.010 |
Why?
|
| India | 1 | 2006 | 234 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 28601 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3147 | 0.010 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2005 | 18 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2008 | 556 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2008 | 594 | 0.010 |
Why?
|
| Sirolimus | 1 | 2007 | 230 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2005 | 26 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2005 | 64 | 0.010 |
Why?
|
| Drug Resistance, Fungal | 1 | 2005 | 31 | 0.010 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2005 | 34 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1992 | 744 | 0.010 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2005 | 10 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 664 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2005 | 56 | 0.010 |
Why?
|
| Inactivation, Metabolic | 1 | 2005 | 25 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 500 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 729 | 0.010 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2005 | 71 | 0.010 |
Why?
|
| Carcinogens | 1 | 2005 | 127 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 484 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1618 | 0.010 |
Why?
|
| Peptides | 1 | 2007 | 708 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2004 | 92 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 2004 | 13 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 2004 | 48 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 11074 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 148 | 0.010 |
Why?
|
| Glutathione | 1 | 2004 | 200 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2002 | 191 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 962 | 0.010 |
Why?
|
| Skin | 1 | 2005 | 545 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 1652 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 1105 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 2595 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 3385 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 1319 | 0.010 |
Why?
|
| Fertility | 1 | 2002 | 260 | 0.010 |
Why?
|
| Calnexin | 1 | 1999 | 12 | 0.010 |
Why?
|
| Microsomes | 1 | 1999 | 35 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1590 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 575 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1999 | 208 | 0.010 |
Why?
|
| Dogs | 1 | 1999 | 613 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1999 | 808 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 6196 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1999 | 359 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1996 | 39 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1996 | 109 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1996 | 305 | 0.010 |
Why?
|
| Antibodies | 1 | 1996 | 322 | 0.010 |
Why?
|
| Gene Expression | 1 | 1999 | 1481 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 982 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 1373 | 0.010 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 1992 | 29 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1992 | 89 | 0.010 |
Why?
|
| Cytosol | 1 | 1992 | 135 | 0.010 |
Why?
|
| Feedback | 1 | 1992 | 144 | 0.010 |
Why?
|
| DNA | 1 | 1996 | 1399 | 0.010 |
Why?
|
| Reference Values | 1 | 1992 | 676 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1992 | 732 | 0.000 |
Why?
|
| Aged | 1 | 2008 | 21025 | 0.000 |
Why?
|
| Cholesterol | 1 | 1992 | 539 | 0.000 |
Why?
|